ORGANIC
LETTERS
XXXX
Vol. XX, No. XX
000–000
Synthesis and Structure Revision
of the C43ÀC67 Part of Amphidinol 3
Makoto Ebine,† Mitsunori Kanemoto,‡ Yoshiyuki Manabe,†,§ Yosuke Konno,†
Ken Sakai,† Nobuaki Matsumori,‡,§ Michio Murata,‡,§ and Tohru Oishi*,†
Department of Chemistry, Faculty and Graduate School of Sciences, Kyushu University,
6-10-1 Hakozaki, Higashi-ku, Fukuoka 812-8581, Japan, Department of Chemistry,
Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka,
Osaka 560-0043, Japan, and JST ERATO Lipid Active Structure, 1-1 Machikaneyama,
Toyonaka, Osaka 560-0043, Japan
Received April 26, 2013
ABSTRACT
Stereoselective synthesis of the C43ÀC67 part of amphidinol 3 (AM3) and its C51-epimer was achieved starting from a common intermediate
corresponding to the tetrahydropyran moiety of AM3, via asymmetric oxidations and JuliaÀKocienski olefination. By comparing NMR data of the
synthetic specimens with those of AM3, the absolute configuration at C51 of AM3 was revised from R to S.
Amphidinol 3 (AM3, 1, Figure 1), produced by the
dinoflagellate Amphidinium klebsii, elicits high antifungal
efficacy with submicromolar IC50 values despite its rela-
tively potent hemolytic activity (EC50 = 0.25 μM).1,2
These biological activities can be accounted for by forma-
tion of ion-permeable pores in a sterol dependent manner.3
The striking structural features of AM3 have attracted
considerable attention from the synthetic community.4À9
Because of the limited availability of the natural product, and
the presence of a number of stereogenic centers on the long
acyclic carbon chain, it has been difficult to determine the
molecular structure of AM3. Although the stereochemistry
of AM3 was determined in 1999 based on the J-based
(3) (a) Echigoya, R.; Rhodes, L.; Oshima, Y.; Satake, M. Harmful
Argae 2005, 4, 383–389. (b) Meng, Y.; Van Wagoner, R. M.; Misner, I.;
Tomas, C.; Wright, J. L. C. J. Nat. Prod. 2009, 73, 409–415. (c) Doi, Y.;
Ishibashi, M.; Nakamichi, H.; Kosaka, T.; Ishikawa, T.; Kobayashi, J.
J. Org. Chem. 1997, 62, 3820–3823. (d) Kubota, T.; Tsuda, M.; Doi, Y.;
Takahashi, A.; Nakamichi, H.; Ishibashi, M.; Fukushi, E.; Kawabata,
J.; Kobayashi, J. Tetrahedron 1998, 54, 14455–14464. (e) Huang, X.-C.;
Zhao, D.; Guo, Y.-W.; Wu, H.-M.; Lin, L.-P.; Wang, Z.-H.; Ding, J.;
Lin, Y.-S. Bioorg. Med. Chem. Lett. 2004, 14, 3117–3120. (f) Huang,
X.-C.; Zhao, D.; Guo, Y.-W.; Wu, H.-M.; Trivellone, E.; Cimino, G.
Tetrahedron Lett. 2004, 45, 5501–5504. (g) Kubota, T.; Takahashi, A.;
Tsuda, M.; Kobayashi, J. Marine Drugs 2005, 3, 113–118. (h) Washida,
K.; Koyama, T.; Yamada, K.; Kita, M.; Uemura, D. Tetrahedron Lett.
2006, 47, 2521–2525. (i) Van Wagoner, R. M.; Deeds, J. R.; Satake, M.;
Ribeiro, A. A.; Place, A. R.; Wright, J. L. C. Tetrahedron Lett. 2008, 49,
6457–6461. (j) Huang, S.-J.; Kuo, C.-M.; Lin, Y.-C.; Chen, Y.-M.; Lu,
C.-K. Tetrahedron Lett. 2009, 50, 2512–2515.
† Kyushu University.
‡ Osaka University.
§ ERATO.
(1) (a) Satake, M.; Murata, M.; Yasumoto, T.; Fujita, T.; Naoki, H.
J. Am. Chem. Soc. 1991, 113, 9859–9861. (b) Murata, M.; Matsuoka, S.;
Matsumori, N.; Paul, G. K.; Tachibana, K. J. Am. Chem. Soc. 1999, 121,
870–871. (c) Swasono, R. T.; Kanemoto, M.; Matsumori, N.; Oishi, T.;
Murata, M. Heterocycles 2011, 82, 1359–1369. (d) Manabe, Y.; Ebine, M.;
Matsumori, N.; Murata, M.; Oishi, T. J. Nat. Prod. 2012, 75, 2003–2006.
(2) Amphidinol congeners: (a) Paul, G. K.; Matsumori, N.; Konoki,
K.; Murata, M.; Tachibana, K. J. Mar. Biotechnol. 1997, 5, 124–128. (b)
Houdai, T.; Matsuoka, S.; Matsumori, N.; Murata, M. Biochim.
Biophys. Acta 2004, 1667, 91–100. (c) Houdai, T.; Matsuoka, S.; Morsy,
N.; Matsumori, N.; Satake, M.; Murata, M. Tetrahedron 2005, 61, 2795–
2802. (d) Morsy, N.; Houdai, T.; Konoki, K.; Matsumori, N.; Oishi, T.;
Murata, M. Bioorg. Med. Chem. 2008, 16, 3084–3090. (e) Swasono, R.;
Mouri, R.; Morsy, N.; Matsumori, N.; Oishi, T.; Murata, M. Bioorg.
Med. Chem. Lett. 2010, 20, 2215–2218.
(4) (a) BouzBouz, S.; Cossy, J. Org. Lett. 2001, 3, 1451–1454. (b)
ꢀ
Cossy, J.; Tsuchiya, T.; Ferrie, L.; Reymond, S.; Kreuzer, T.; Colobert,
ꢀ
F.; Jourdain, P.; Marko, I. E. Synlett 2007, 2286–2288. (c) Colobert, F.;
ꢀ
Kreuzer, T.; Cossy, J.; Reymond, S.; Tsuchiya, T.; Ferrie, L.; Marko,
I. E.; Jourdain, P. Synlett 2007, 2351–2354. (d) Cossy, J.; Tsuchiya, T.;
ꢀ
Reymond, S.; Kreuzer, T.; Colobert, F.; Marko, I. E. Synlett 2009,
2706–2710.
(5) (a) Flamme, E. M.; Roush, W. R. Org. Lett. 2005, 7, 1411–1414.
(b) Hicks, J. D.; Flamme, E. M.; Roush, W. R. Org. Lett. 2005, 7, 5509–
5512. (c) Hicks, J. D.; Roush, W. R. Org. Lett. 2008, 10, 681–684.
(6) (a) de Vicente, J.; Betzemeier, B.; Rychnovsky, S. D. Org. Lett.
2005, 7, 1853–1856. (b) de Vicente, J.; Huckins, J. R.; Rychnovsky, S. D.
Angew. Chem., Int. Ed. 2006, 45, 7258–7262. (c) Huckins, J. R.; de
Vicente, J.; Rychnovsky, S. D. Org. Lett. 2007, 9, 4757–4760.
r
10.1021/ol401176a
XXXX American Chemical Society